ALX ONCOLOGY HOLDINGS INC (ALXO): Nasdaq/NYSE listing notice — ALX Oncology receives Nasdaq bid price non-compliance notice; 180-day cure until Oct 20, 2025

ALX ONCOLOGY HOLDINGS INC

Nasdaq notified ALXO on Apr 23, 2025 that its common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days.
Company has until Oct 20, 2025 to regain compliance by closing at or above $1.00 for at least ten consecutive business days.
If not cured, ALXO may seek a second 180-day period by transferring to the Nasdaq Capital Market, subject to eligibility.
Potential cure actions include a reverse stock split; failure to regain compliance could lead to delisting.
ALXO intends to actively monitor bid price and assess options, but no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

ALX ONCOLOGY HOLDINGS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

April 23, 2025, ALX Oncology Holdings Inc. (the “Company”) received a written notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has not been in compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market set forth in Nasdaq Listing Rule 5450(a)(1) for a period of 30 consecutive business days (the “Notice”). The Notice has no immediate effect on the listing of the Company’s stock on the Nasdaq Global Select Market, subject to the Company’s compliance with the other lis

View on SEC.gov

Browse all listing & compliance notices →

ALX ONCOLOGY HOLDINGS INC filing history →

Source: SEC EDGAR

accession 0000950170-25-058687

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.